Page last updated: 2024-12-07

hydroxybenzylpindolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydroxybenzylpindolol is a synthetic β-adrenergic receptor antagonist with a unique pharmacological profile. Its synthesis involves several steps, starting with the reaction of pindolol with benzoyl chloride, followed by a series of reactions to introduce the hydroxybenzyl group. It exhibits high affinity for both β1 and β2 adrenergic receptors, making it a potent blocker of the sympathetic nervous system. Due to its complex interactions with various receptors, hydroxybenzylpindolol has been investigated for a range of therapeutic applications, including the treatment of hypertension, migraine, and anxiety disorders. Research into hydroxybenzylpindolol continues to explore its potential as a therapeutic agent, particularly in the context of neurodegenerative diseases and cognitive impairment, where its modulation of both β-adrenergic and serotonergic receptors may offer unique benefits.'

hydroxybenzylpindolol: structure; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID112184
MeSH IDM0059323

Synonyms (13)

Synonym
4-(2-((2-hydroxy-3-(1h-indol-4-yloxy)propyl)amino)-2-methylpropyl)phenol
PDSP2_000151
PDSP1_000152
hydroxybenzylpindolol
69925-27-5
4-[2-[[2-hydroxy-3-(1h-indol-4-yloxy)propyl]amino]-2-methylpropyl]phenol
nsc_112184
cas_112184
bdbm81450
hydroxybenzylpindolol,(+/-)
phenol, 4-(2-((2-hydroxy-3-(1h-indol-4-yloxy)propyl)amino)-2-methylpropyl)-
DTXSID60990190
4-[2-({2-hydroxy-3-[(1h-indol-4-yl)oxy]propyl}amino)-2-methylpropyl]phenol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (96.30)18.7374
1990's1 (3.70)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.79 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]